When used in conjunction with other GLP-1 based therapies like Cagrisema, this dual-action could potentiate greater advancements toward effective weight control as well as enhanced glycemic managementa substantial boon for individuals dealing with obesity or diabetes-related health issues
Discuss with your provider if you frequently miss doses, as this may affect your treatment outcomes and require additional support or planning tools
Problems occurred more often in women, and more often in people ages 45-64
For others, it may be lowering the dose to reduce side effects, cost, or treatment burden
Our discoveries have the potential to change whats medically possible within our lifetimes
By reconstructing weight history, we have shown that the risks of overweight and obesity are greater than commonly appreciated, Stokes says